The trademark CAVIVA was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on September 3, 2020, and received one opposition filed on December 3, 2020 by Apogepha Arzneimittel GmbH on Likelihood of confusion. the opponent was represented by KAILUWEIT & UHLEMANN PATENTANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 3, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).